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Abstract 
The regulation of protein stability is a fundamental issue for biophysical processes, but there has not previously been 
a convenient and unbiased method of identifying regulators of protein stability. However, as reported in the article 
entitled “A genome-scale CRISPR–Cas9 screening method for protein stability reveals novel regulators of Cdc25A,” 
recently published in Cell Discovery, our team developed a protein stability regulators screening assay (Pro-SRSA) by 
combining the whole-genome clustered regularly interspaced short palindromic repeats Cas9 (CRISPR–Cas9) library 
with a dual-fluorescence-based protein stability reporter and high-throughput sequencing to screen for regulators 
of protein stability. Based on our findings, we are confident that this efficient and unbiased screening method at the 
genome scale will be used by researchers worldwide to identify regulators of protein stability.
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Main text
Fine-tuned degradation of proteins plays a crucial role in 
a variety of physiological conditions, including cell cycle 
progression, cell growth, differentiation, and signaling 
transduction. The inappropriate degradation of some 
cancer-related proteins may induce cellular transfor-
mation and tumorigenesis [1]. Thus, understanding the 
precise regulation of protein degradation, especially for 
oncogenes and tumor suppressors, is important not only 
for understanding the biological mechanisms of cancer 
but also for developing therapeutic interventions. How-
ever, due to the lack of an efficient method, an unbiased 
and universal delineation of the regulators of protein 
homeostasis has not been previously possible. But now, 
based on the study reported in the article entitled “A 
genome-scale CRISPR–Cas9 screening method for pro-
tein stability reveals novel regulators of Cdc25A,” which 
was published in Cell Discovery, such an efficient method 
has been developed [2]. In this study, our team devised 
a protein stability regulators screening assay (Pro-SRSA) 
to screen for regulators of protein stability by combining 
the whole-genome clustered regularly interspaced short 
palindromic repeats Cas9 (CRISPR–Cas9) library with 
a dual-fluorescence-based protein stability reporter and 
high-throughput sequencing.
The workflow of Pro-SRSA is divided into three steps 
(Fig.  1). The first step: genome-scale gene knockout. 
We infected the cells with lenti-CRISPR–Cas9 library 
at a low multiplicity of infection to control only one 
transgene copy number in most of the infected cells. 
Then, the cells were selected by puromycin for 1  week; 
during this period, the single-guide RNAs (sgRNAs) 
guided the Cas9 nuclease to cut the target sites, which 
introduced the indels and frame-shift of target genes 
through non-homologous end repair [3]. As a system for 
performing genome-scale loss-of-function screening, the 
CRISPR–Cas9 library was shown to be an easy and effi-
cient method for gene knockouts [4, 5]. The second step: 
infection of a protein stability reporter. We developed 
an adenovirus reporter vector called pAd-DsRed-IRES-
EGFP-X. In this dual-fluorescence reporter, a cassette 
containing DsRed-IRES-EGFP-X was used to reflect the 
stability of protein X. The internal ribosome entry site 
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(IRES) permits translation of both Discosoma sp. red 
fluorescent protein (DsRed) and enhanced green fluores-
cence protein (EGFP)-X fusion proteins at a certain ratio 
[6]; knockout of any genes that affect the X protein stabil-
ity would change the ratio of EGFP/DsRed, which would 
be monitored by flow cytometry. By combining the 
CRISPR–Cas9 library and the dual-fluorescence reporter, 
we were able to sort the cells with top ratio of EGFP/
DsRed, then extract the genome DNA of the sorted and 
unsorted control cells and, by polymerase chain reaction, 
amplify the sgRNAs. Finally, the last step: high-through-
put sequencing. By analyzing the enrichment of sgRNAs, 
we were able to determine which knockout contributed 
to the stabilization of X protein.
Using Pro-SRSA screening for cell division cycle 25A 
(Cdc25A) regulators, we found that cullin 4B (Cul4B)–
damage-specific DNA binding protein 1 (DDB1)—
DDB1 and CUL4 associated factor 8 (DCAF8) complex 
(Cul4B-DDB1DCAF8) is an E3 ligase for the degrada-
tion of Cdc25A. More interestingly, the screening also 
revealed that acetylation of Cdc25A at lysine 150, which 
is acetylated by E1A binding protein p300/CREB binding 
protein (p300/CBP) and deacetylated by histone deacety-
lase 3 (HDAC3), stabilizes the protein. In addition, using 
p53 as another example in our Pro-SRSA, we discovered 
a new degradation mechanism for p53 (manuscript in 
preparation).
Conclusions
Pro-SRSA is a powerful screening method that could 
help researchers better understand cellular protein reg-
ulation in a variety of physiological and/or pathologi-
cal processes, especially for the abnormal expression of 
oncogenes and tumor suppressors during tumorigen-
esis. Genome-scale screening for regulators of protein 
stability may open many new avenues for the treatment, 
perhaps even the curing, of diseases. Thus, we are confi-
dent that this easy and efficient method would be help-
ful for researchers focusing on protein degradation.
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Fig. 1 The workflow of the protein stability regulators screening assay (Pro-SRSA). CRISPR clustered regularly interspaced short palindromic repeat, 
FACS fluorescence-activated cell sorting, EGFP enhanced green fluorescence protein, DsRed Discosoma sp. red fluorescent protein, sgRNA single-
guide RNA
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